Penobscot Investment Management Company Inc. lessened its stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 7.7% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 68,009 shares of the company's stock after selling 5,680 shares during the quarter. Procter & Gamble comprises about 0.9% of Penobscot Investment Management Company Inc.'s investment portfolio, making the stock its 27th largest holding. Penobscot Investment Management Company Inc.'s holdings in Procter & Gamble were worth $10,835,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors also recently modified their holdings of PG. Kingstone Capital Partners Texas LLC increased its holdings in shares of Procter & Gamble by 655,209.0% in the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company's stock worth $11,832,680,000 after acquiring an additional 76,017,350 shares in the last quarter. Nuveen LLC bought a new stake in shares of Procter & Gamble in the first quarter worth about $1,954,941,000. Price T Rowe Associates Inc. MD increased its holdings in shares of Procter & Gamble by 13.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock worth $3,660,737,000 after acquiring an additional 2,466,308 shares in the last quarter. Invesco Ltd. increased its holdings in shares of Procter & Gamble by 19.8% in the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock worth $2,299,580,000 after acquiring an additional 2,228,151 shares in the last quarter. Finally, Assenagon Asset Management S.A. boosted its position in shares of Procter & Gamble by 140.4% during the first quarter. Assenagon Asset Management S.A. now owns 2,663,246 shares of the company's stock worth $453,870,000 after buying an additional 1,555,504 shares during the period. 65.77% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
PG has been the subject of several recent research reports. Wells Fargo & Company reduced their price objective on Procter & Gamble from $173.00 to $170.00 and set an "overweight" rating for the company in a research report on Thursday, September 25th. Evercore ISI reaffirmed an "in-line" rating and set a $170.00 price objective (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. UBS Group set a $180.00 price objective on Procter & Gamble and gave the stock a "buy" rating in a research report on Wednesday, July 30th. Barclays reduced their price objective on Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating for the company in a research report on Wednesday. Finally, Weiss Ratings reaffirmed a "hold (c+)" rating on shares of Procter & Gamble in a research report on Saturday, September 27th. Eleven investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat.com, Procter & Gamble presently has an average rating of "Moderate Buy" and a consensus target price of $173.11.
Get Our Latest Analysis on Procter & Gamble
Procter & Gamble Stock Performance
Shares of NYSE PG opened at $152.19 on Friday. The stock has a 50 day moving average price of $155.51 and a 200 day moving average price of $160.00. Procter & Gamble Company has a 52 week low of $149.91 and a 52 week high of $180.43. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. The stock has a market capitalization of $356.20 billion, a PE ratio of 23.38, a price-to-earnings-growth ratio of 4.02 and a beta of 0.36.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, beating the consensus estimate of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The firm had revenue of $20.89 billion during the quarter, compared to analysts' expectations of $20.79 billion. During the same period in the prior year, the firm posted $1.40 earnings per share. The business's quarterly revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were given a $1.0568 dividend. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date of this dividend was Friday, July 18th. Procter & Gamble's dividend payout ratio (DPR) is presently 64.98%.
Insider Buying and Selling
In other news, CEO Jennifer L. Davis sold 8,596 shares of the firm's stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,351,892.92. Following the completion of the sale, the chief executive officer directly owned 64,991 shares of the company's stock, valued at $10,221,134.57. This trade represents a 11.68% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, insider Susan Street Whaley sold 1,000 shares of the firm's stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $156.84, for a total value of $156,840.00. Following the completion of the sale, the insider directly owned 28,436 shares of the company's stock, valued at approximately $4,459,902.24. The trade was a 3.40% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 120,181 shares of company stock valued at $18,918,012. Insiders own 0.20% of the company's stock.
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report